IL123195A - Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them - Google Patents

Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Info

Publication number
IL123195A
IL123195A IL12319598A IL12319598A IL123195A IL 123195 A IL123195 A IL 123195A IL 12319598 A IL12319598 A IL 12319598A IL 12319598 A IL12319598 A IL 12319598A IL 123195 A IL123195 A IL 123195A
Authority
IL
Israel
Prior art keywords
alkyl
ring
group
alkenyl
steroid
Prior art date
Application number
IL12319598A
Other languages
English (en)
Hebrew (he)
Other versions
IL123195A0 (en
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL123195A0 publication Critical patent/IL123195A0/xx
Publication of IL123195A publication Critical patent/IL123195A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12319598A 1997-02-21 1998-02-05 Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them IL123195A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97102884 1997-02-21

Publications (2)

Publication Number Publication Date
IL123195A0 IL123195A0 (en) 1998-09-24
IL123195A true IL123195A (en) 2002-11-10

Family

ID=8226513

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12319598A IL123195A (en) 1997-02-21 1998-02-05 Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them

Country Status (27)

Country Link
US (2) US6077873A (de)
EP (1) EP0869132B1 (de)
JP (1) JP4392066B2 (de)
KR (1) KR19980071540A (de)
CN (2) CN101092442A (de)
AR (1) AR011680A1 (de)
AT (1) ATE205217T1 (de)
AU (1) AU723713B2 (de)
BR (1) BR9800718B1 (de)
CA (1) CA2229960C (de)
CZ (1) CZ50598A3 (de)
DE (1) DE69801539T2 (de)
DK (1) DK0869132T3 (de)
ES (1) ES2164400T3 (de)
HK (1) HK1016188A1 (de)
HU (1) HU223755B1 (de)
ID (1) ID19947A (de)
IL (1) IL123195A (de)
NO (1) NO310724B1 (de)
NZ (1) NZ329789A (de)
PL (1) PL188079B1 (de)
PT (1) PT869132E (de)
RU (1) RU2182153C2 (de)
SG (1) SG60203A1 (de)
TR (1) TR199800282A1 (de)
TW (1) TW403736B (de)
ZA (1) ZA981344B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
CO5271709A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
TWI225068B (en) 2000-06-06 2004-12-11 Akzo Nobel Nv Anellated steroid compounds having contraceptive and anti-osteoporosis activity
JP2002241395A (ja) * 2001-02-16 2002-08-28 Taiho Yakuhin Kogyo Kk エストラ−４，６−ジエン−３，１７−ジオンの製造方法
US7250289B2 (en) 2002-11-20 2007-07-31 Affymetrix, Inc. Methods of genetic analysis of mouse
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
EP2127656A4 (de) * 2006-12-20 2010-03-03 Landsteiner Scient S A De C V Zusammensetzungen von risedronat und vitamin d3
TW201109346A (en) * 2009-06-10 2011-03-16 Organon Nv Substituted 16,17-annellated steroid compounds for use in women's healthcare
US8367648B2 (en) 2009-06-10 2013-02-05 Msd Oss B.V. Substituted 16,17-annellated steroid compounds for use in womens healthcare

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001958A2 (de) * 1989-08-04 1991-02-21 Schering Aktiengesellschaft Berlin Und Bergkamen 11β-ARYL-GONA-4,9-DIEN-3-ONE
DE59005594D1 (de) * 1989-08-04 1994-06-09 Schering Ag 11 Beta-substituierte 16 alpha, 17alpha-Methylen-estra-4,9-dien-3-one.
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity

Also Published As

Publication number Publication date
TW403736B (en) 2000-09-01
JPH10273499A (ja) 1998-10-13
MX9801428A (es) 1998-12-31
HU9800373D0 (en) 1998-04-28
PT869132E (pt) 2002-01-30
ATE205217T1 (de) 2001-09-15
CA2229960C (en) 2007-12-18
US6077873A (en) 2000-06-20
SG60203A1 (en) 1999-02-22
CN1197076A (zh) 1998-10-28
BR9800718A (pt) 1999-06-29
BR9800718B1 (pt) 2009-08-11
NO310724B1 (no) 2001-08-20
PL188079B1 (pl) 2004-12-31
HUP9800373A2 (hu) 1998-11-30
ES2164400T3 (es) 2002-02-16
AU723713B2 (en) 2000-09-07
CA2229960A1 (en) 1998-08-21
EP0869132B1 (de) 2001-09-05
NO980737D0 (no) 1998-02-20
HUP9800373A3 (en) 1999-06-28
DE69801539D1 (de) 2001-10-11
US6313180B1 (en) 2001-11-06
ZA981344B (en) 1998-08-27
DK0869132T3 (da) 2002-01-07
CZ50598A3 (cs) 1998-09-16
DE69801539T2 (de) 2002-04-18
CN101092442A (zh) 2007-12-26
ID19947A (id) 1998-08-27
HU223755B1 (hu) 2005-01-28
TR199800282A1 (xx) 1998-09-21
NO980737L (no) 1998-08-24
PL324939A1 (en) 1998-08-31
IL123195A0 (en) 1998-09-24
EP0869132A1 (de) 1998-10-07
AR011680A1 (es) 2000-08-30
HK1016188A1 (en) 1999-10-29
AU5541298A (en) 1998-08-27
JP4392066B2 (ja) 2009-12-24
RU2182153C2 (ru) 2002-05-10
CN100522984C (zh) 2009-08-05
NZ329789A (en) 1999-09-29
KR19980071540A (ko) 1998-10-26

Similar Documents

Publication Publication Date Title
US5866560A (en) 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
DE19635525A1 (de) 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
JPH021159B2 (de)
US6077873A (en) Steroid compounds having contraceptive and anti-osteoporosis activity
JPS6013796A (ja) １−アルキル−アンドロスタ−１，４−ジエン−３，１７−ジオン、その製法及び該化合物を含有するエストロゲン生合成を阻害する製薬的製剤
EP1237904B1 (de) 14,15-beta-methylen substituierte androgene
JPH0564639B2 (de)
IL148116A (en) Non-aromatic estrogenic steroids with position 11 hydrocarbon converters
KR100341066B1 (ko) 게스타겐활성의19,11-다리결합4-에스트렌
MXPA98001428A (en) Steroid compounds that have anticonceptive and anti-osteoporo activity
KR100730010B1 (ko) 신규 안드로겐
GB2185258A (en) 10 beta -Halo-alkynyl estrene derivatives and process for their preparation
AU2001258386A1 (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
WO2002000682A1 (en) 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity
WO1995011915A1 (de) 10,11β-C2-ÜBERBRÜCKTE STEROIDE
GB2195639A (en) Polyconjugated androstenediones and process for their preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees